Company
Headquarters: New York, NY, United States
CEO: Mr. Eli Decatur Casdin
$687.9 Million
USD as of Dec. 1, 2021
Company | Market Cap (USD) |
---|---|
Berkshire Hathaway | $991.39 B |
JPMorgan | $744.02 B |
Visa | $635.57 B |
Mastercard | $490.32 B |
Bank of America | $353.07 B |
CM Life Sciences III Inc. intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2021 and is based in New York, New York.
Last Financial Reports Date | Sept. 30, 2021 |
Revenue TTM | $None |
EBITDA | $None |
Gross Profit TTM | $None |
Profit Margin | 0.00% |
Operating Margin | 0.00% |
Quarterly Revenue Growth | % |
CM Life Sciences III, Inc. has the following listings and related stock indices.
Stock: NASDAQ: CMLT wb_incandescent